| scholarly article | Q13442814 |
| P2093 | author name string | Jill M Cholette | |
| Michael P McDermott | |||
| Norma B Lerner | |||
| Richard P Phipps | |||
| Neil Blumberg | |||
| Kelly F Gettings | |||
| P2860 | cites work | Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. | Q53850992 |
| Soluble CD40 Ligand in Acute Coronary Syndromes | Q58816350 | ||
| CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism | Q63354517 | ||
| Age-related changes in thrombopoietin in children: reference interval for serum thrombopoietin levels | Q73079796 | ||
| Platelet-derived CD40L: the switch-hitting player of cardiovascular disease | Q74627856 | ||
| Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis | Q77411828 | ||
| Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis | Q77768132 | ||
| Developmental haemostasis. Impact for clinical haemostasis laboratories | Q82627378 | ||
| Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation | Q83118100 | ||
| CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 | ||
| Antiplatelet therapy in children | Q28218171 | ||
| Expression of CD154 (CD40 ligand) by human lung fibroblasts: differential regulation by IFN-gamma and IL-13, and implications for fibrosis | Q31036855 | ||
| Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer | Q31811299 | ||
| Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. | Q33183129 | ||
| Cardiopulmonary bypass induces release of soluble CD40 ligand | Q33342885 | ||
| The soluble CD40 ligand sCD154 in systemic lupus erythematosus | Q33858548 | ||
| CD40 ligation induces tissue factor expression in human vascular smooth muscle cells | Q35793488 | ||
| Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury | Q35849153 | ||
| New links between inflammation and thrombosis | Q36098709 | ||
| Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system | Q36216095 | ||
| CD40 ligand binds to alpha5beta1 integrin and triggers cell signaling | Q40191634 | ||
| CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. | Q40658295 | ||
| Soluble CD40L and cardiovascular risk in women | Q40677583 | ||
| Should soluble CD40 ligand be measured from serum or plasma samples? | Q44478664 | ||
| Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells | Q45012612 | ||
| Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease | Q46794553 | ||
| Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation? | Q47355225 | ||
| The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. | Q52962713 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 50-4, 54.e1 | |
| P577 | publication date | 2007-10-24 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Developmental changes in soluble CD40 ligand | |
| P478 | volume | 152 |
| Q38061672 | Plasma-mediated immune suppression: a neonatal perspective |
| Q28397818 | Serum and cerebrospinal fluid immune mediators in children with autistic disorder: a longitudinal study |
| Q36445381 | The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects |
Search more.